The National Centre for Research and Development (NCBR) has launched another sectoral programme. The NCBR has allocated PLN 190 million to support R&D in the pharmaceutical sector and increase research results commercialisation in neuromedicine.
- PLN 190 million invested in the pharmaceutical sector and neuromedicine is an injection which gives a chance for a breakthrough solutions created by Polish companies. All the time we are waiting for effective drugs for Alzheimer and Parkinson diseases, diabetes and most cancers - says Deputy Prime Minister and Minister of Science and Higher Education Jarosław Gowin.
Implemented by the NCBR under the Operational Programme Smart Growth, INNONEUROPHARM aims to increase competitiveness and innovation of the Polish pharmaceutical sector - including neuromedicine - in the 2026 perspective. It was launched in response to a joint initiative of the Polish Association of Pharmaceutical Industry Employers and Polish Platform of Innovative Neuromedicine. Dedicated to entrepreneurs, the programme is the first of three new sectoral programmes launched by the NCBR this year.
- Sectoral programmes established by the NCBR in cooperation with the business sector are direct responses to the needs of individual economy sectors that rely on growth through innovation. Today another branch joins those already benefiting from NCBR support. A branch whose development is of particular importance, both in the context of civilisation challenges as well as of global competition of pharmaceutical companies - says NCBR Director Prof. Maciej Chorowski.
The budget of the call for proposals announced by the NCBR on 20 January totals PLN 190 million. Enterprises or their consortia will be eligible to apply for grants worth up to PLN 40 million. The call will run from 22 February to 7 April 2017.
Implementation of the program will contribute to increasing R&D activities of enterprises and, consequently, to the growth of innovation within the Polish pharmaceutical sector. INNONEUROPHARM will see the implementation of innovative projects in areas such as:
More information about INNONEUROPHARM is available on the NCBR website
The National Centre for Research and Development
47a Nowogrodzka Str., 00-695 Warszawa office: +48 22 39 07 401 fax: +48 22 20 13 408
REGON: 141032404 NIP: 701-007-37-77